Physician profile
Shane Austin
NPI 1669899894
$1,720.95
in general payments reported to CMS, 2019-2025
10 companies · $1,016 in 2025
The $1,016 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2022: $214 · 2023: $197 · 2024: $146 · 2025: $1,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781 · Travel and Lodging: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $780.69 |
| Travel and Lodging | $578.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,088.49 | 2022-2025 | Watchman Access System, Watchman Flx |
| Inari Medical, INC. | $197.01 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Gilead Sciences, INC. | $124.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $87.49 | 2022-2025 | |
| Exact Sciences Corporation | $63.64 | 2025 | The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $46.97 | 2019-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $40.07 | 2022 | |
| Pfizer INC. | $38.73 | 2024 | |
| Lilly USA, LLC | $17.67 | 2025 | Mounjaro, Zepbound |
| Medicure Pharma INC. | $15.89 | 2025 | Zypitamag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.